
Imirox 500mg/500mg Injection
Marketer
Cellrox Life Sciences
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview Imirox 500mg/500mg Injection
Combiflox 500mg/500mg Injection, a dual-antibiotic formulation, targets severe bacterial infections. This medication combats infectious agents, preventing infection spread. Administration must be under a physician's direct supervision; strict adherence to the prescribed schedule is crucial, completing the full course even with symptom improvement. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation (redness, swelling, pain), typically resolving spontaneously. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, respiratory distress) require prompt emergency care. Inform your doctor of all current medications, particularly if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs.
Uses of Imirox 500mg/500mg Injection
Life-threatening bacterial infections
Major Benefits of Imirox 500mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Imirox 500mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Imirox 500mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Imirox 500mg/500mg Injection works:
Imirox Injection, containing 500mg of each Imipenem and Cilastatin, utilizes a dual-drug approach to combat bacterial infection. Imipenem, the antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to survive. Cilastatin, a dehydropeptidase I inhibitor, safeguards Imipenem from premature enzymatic degradation (by dehydropeptidase I), thereby extending its therapeutic effectiveness within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imirox 500mg/500mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Imirox 500mg/500mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
The use of Imirox 500mg/500mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Administering Imirox 500mg/500mg Injection may induce adverse reactions potentially impairing driving capabilities. Certain side effects, including hallucinations (visual, auditory, or sensory), associated with this medication, might compromise some individuals' ability to operate a vehicle.
KidneyCAUTION
Exercise caution when administering Imirox 500mg/500mg Injection to individuals with impaired renal function. Dosage modification for Imirox 500mg/500mg Injection may be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Imirox 500mg/500mg Injection to individuals with hepatic impairment. Seek medical advice.
What if you forget to take Imirox 500mg/500mg Injection :
Should you forget to take a dose of Imirox 500mg/500mg Injection, seek medical advice immediately.
Facts to Know About Imirox 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
